# RAZADYNE ER
> **NDA021615** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2005-04-01
## Drug
- **FDA Application Number:** NDA021615
- **Application type:** New Drug Application
- **Brand name:** RAZADYNE ER
- **Generic name:** Galantamine Hydrobromide
- **Active ingredients:** GALANTAMINE HYDROBROMIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** JANSSEN PHARMS
- **First approval:** 2005-04-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021615)
---
*AI Analytics · CC0 1.0*